Загрузка...

Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides

Antiphospholipid syndrome (APS) is characterized by recurrent fetal loss, repeated thromboembolic phenomena, and thrombocytopenia. The syndrome is believed to be caused by antiphospholipid beta-2-glycoprotein-I (β2GPI)-dependent Abs or anti-β2GPI Abs by themselves. Using a hexapeptide phage display...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Blank, Miri, Shoenfeld, Yehuda, Cabilly, Shmuel, Heldman, Yehudit, Fridkin, Mati, Katchalski-Katzir, Ephraim
Формат: Artigo
Язык:Inglês
Опубликовано: The National Academy of Sciences 1999
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC21834/
https://ncbi.nlm.nih.gov/pubmed/10220436
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!